Modification of MSCs with aHSCs-Targeting Peptide pPB for Enhanced Therapeutic Efficacy in Liver Fibrosis

Scientists engineered pPB peptide-functionalized MSCs via hydrophobic insertion of DMPE-PEG-pPB into the MSC membrane, creating a targeted “MSC-pPB-activated hepatic stellate cell” delivery system.